Main Story
-
Shell completes sale of Jiffy Lube International and Premium Velocity Auto to Monomoy Capital Partners
HOUSTON, July 1, 2026 /PRNewswire/ — Pennzoil Quaker State Company DBA SOPUS Products, a wholly owned subsidiary of Shell USA, Inc., that comprises Shell’s United States (“U.S.”) lubricants business, has completed the previously announced sale of Jiffy Lube International (JLI) and its subsidiary Premium Velocity Auto (PVA) LLC business to an affiliate of Monomoy Capital…
Automobile
Tech
Entertainment
-
Dance Without Borders: BYU Ballroom Dance Gives Historic Performances in India
New Delhi | Bengaluru, India The BYU Ballroom Dance Company lit up stages in India for the first time, enchanting over 1,000 audience members with show-stopping performances held on 4 and 6 June 2026 in the nation’s capital and a grand finale in Bengaluru on 9 June. Distinguished guests, including government, interfaith, and community leaders,…
Health
-
Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report
Pinellas Park, FL, July 02, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. JellyForce is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, especially if currently taking prescription medications. JellyForce is a gummy dietary supplement formulated for men,…
-
Saroj Super Speciality Hospital Inaugurated in Nava Raipur
NAVA RAIPUR, India, July 2, 2026 /PRNewswire/ — Saroj Super Speciality Hospital, a unit of Ganesh Das Chawla Charitable Trust, formally inaugurated its new healthcare facility in Nava Raipur, Chhattisgarh, marking a significant step towards strengthening access to quality healthcare in the region. With a legacy of over 27 years in healthcare, Saroj Hospital has expanded…
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
TOKYO, July 01, 2026 (GLOBE NEWSWIRE) — GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi…
-
Bredehorst Clinic Medical Management, Germany’s Leading Healthcare Procurement Specialist, partners with Sigla
DÜSSELDORF, Germany, July 1, 2026 /PRNewswire/ — Düsseldorf – Sigla, a European private equity firm, is pleased to announce its investment in Bredehorst Clinic Medical Management GmbH (“BCMM” or “the Company”), Germany’s leading provider of tech-enabled procurement optimisation services for hospitals and care facilities. BCMM improves the purchasing of German healthcare providers, particularly hospitals, by…
-
Morepen Starts Commercial Supplies Under its Rs. 825 Crore CDMO Mandate; First Rs. 50 Crore Dispatch Already Completed in Q1FY2026-27
Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation…
-
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
June 30, 2026 20:38 ET | Source: Mesoblast Limited NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
